Insider Transactions in Q4 2017 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q4 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 10
2017
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
355,000
+10.9%
|
$6,035,000
$17.0 P/Share
|
|
Oct 10
2017
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,546,295
+50.0%
|
-
|
|
Oct 10
2017
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
355,000
+27.48%
|
$6,035,000
$17.0 P/Share
|
|
Oct 10
2017
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
582,010
+50.0%
|
-
|
|
Oct 05
2017
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
885,000
+31.88%
|
$15,045,000
$17.0 P/Share
|
|
Oct 05
2017
|
Baker Bros. Advisors LP |
BUY
Conversion of derivative security
|
Indirect |
1,164,020
+50.0%
|
-
|